Amurensin G

Views 170
Jump to
Abstracts Focused Research Topics
Download the GMI DOC on this Topic

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research
5 Diseases Researched for Amurensin G
NameACCKFocus
Breast Cancer: Drug Resistant210Locked
Cancers: Drug Resistant210Locked
Breast Cancer15Locked
Leukemia: Chronic myelogenous leukemia (CML) 15Locked
Parkinson's Disease15Locked
8 Pharmacological Actions Researched for Amurensin G
NameACCKFocus
Chemosensitizer210Locked
Anti-Angiogenic15Locked
Anti-Tumor15Locked
Antineoplastic Agents15Locked
Apoptotic15Locked
Hypoxia-inducible factor-1 (HIF-1) inhibitor15Locked
Neuroprotective Agents15Locked
Vascular Endothelial Growth Factor A Inhibitor15Locked

View the Evidence:
4 Abstracts with Amurensin G Research

[+]

Amurensin G augmented the cytotoxic and apoptotic effects of TRAIL in TRAIL resistant leukemic cells.Jul 31, 2012

Pubmed Data : Biochem Pharmacol. 2012 Aug 1 ;84(3):402-10. Epub 2012 Mar 29. PMID: 22483777
Article Published Date : Jul 31, 2012
Study Type : Human In Vitro
Additional Links
Substances : Amurensin G
Diseases : Cancers: Drug Resistant, Leukemia: Chronic myelogenous leukemia (CML)
Pharmacological Actions : Apoptotic, Chemosensitizer
Additional Keywords : Cancer Stem Cells, Gene Expression Regulation, Natural Substance Synergy
[+]

Amurensin G had significant antiangiogenic and antitumor growth effects in tamoxifen resistant breast cancer.Sep 30, 2012

Pubmed Data : Food Chem Toxicol. 2012 Oct ;50(10):3625-34. Epub 2012 Jul 27. PMID: 22842120
Article Published Date : Sep 30, 2012
Study Type : Human In Vitro
Additional Links
Substances : Amurensin G
Diseases : Breast Cancer, Breast Cancer: Drug Resistant
Pharmacological Actions : Anti-Angiogenic, Anti-Tumor, Antineoplastic Agents, Hypoxia-inducible factor-1 (HIF-1) inhibitor, Vascular Endothelial Growth Factor A Inhibitor
Additional Keywords : Epigenetic Modification In Cancer, Gene Expression Regulation
[+]

Amurensin G induces autophagy and attenuates cellular toxicities in a rotenone model of Parkinson's disease.Mar 28, 2013

Pubmed Data : Biochem Biophys Res Commun. 2013 Mar 29 ;433(1):121-6. Epub 2013 Feb 26. PMID: 23485458
Article Published Date : Mar 28, 2013
Study Type : Human In Vitro
Additional Links
Substances : Amurensin G
Diseases : Parkinson's Disease
Pharmacological Actions : Neuroprotective Agents
Additional Keywords : Phytotherapy
Problem Substances : Rotenone
[+]

Amurensin G. was a potent SIRT1 Inhibitor which led to the down regulation of multidrug resistance.Oct 31, 2010

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Mol Pharmacol. 2010 Nov ;78(5):855-64. Epub 2010 Aug 16. PMID: 20713551
Article Published Date : Oct 31, 2010
Study Type : Animal Study, Human In Vitro
Additional Links
Substances : Amurensin G
Diseases : Breast Cancer: Drug Resistant, Cancers: Drug Resistant
Pharmacological Actions : Chemosensitizer
Additional Keywords : Gene Expression Regulation, Natural Substance/Drug Synergy, Plant Extracts
Problem Substances : Doxorubicin

Copyright: radiantskies / 123RF Stock Photo

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.